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Abstract
Robertsonian (Rb) translocation chromosomes occur
in human and murine cancers and involve the aberrant
joining of two acrocentric chromosomes in humans
and two telocentric chromosomes in mice. Mecha-
nisms leading to their generation remain elusive, but
models for their formation have been proposed. They
include breakage of centromeric sequences and their
subsequent fusions, centric misdivision, misparing
between highly repetitive sequences of p-tel or p-arm
repeats, and recombinational joining of centromeres
and/or centromeric fusions. Here, we have investi-
gated the role of the oncoprotein c-Myc in the forma-
tion of Rb chromosomes in mouse cells harboring
exclusively telocentric chromosomes. In mouse plas-
macytoma cells with constitutive c-Myc deregulation
and in immortalized mouse lymphocytes with con-
ditional c-Myc expression, we show that positional
remodeling of centromeres in interphase nuclei co-
incides with the formation of Rb chromosomes. Fur-
thermore, we demonstrate that c-Myc deregulation in
amyc box II–dependent manner is sufficient to induce
Rb translocation chromosomes. Because telomeric
signals are present at all joined centromeres of Rb
chromosomes, we conclude that c-Myc mediates Rb
chromosome formation in mouse cells by telomere
fusions at centromeric termini of telocentric chromo-
somes. Our findings are relevant to the understanding
of nuclear chromosome remodeling during the initia-
tion of genomic instability and tumorigenesis.
Neoplasia (2007) 9, 578–588
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Introduction
c-Myc deregulation is frequent in human and murine can-
cers [1–3]. In fact, > 70% of all cancers—including breast,
ovarian, prostate, colon, liver, and gastric cancers; neuro-
blastoma; myeloma; and Burkitt’s lymphoma [1,2] (http://
www.myccancergene.org/site/cancerDB.asp)—have a
known Myc component. Invariably, these cancers display Myc
oncoprotein deregulation/overexpression, which is achieved
through various mechanisms, such as enhanced mRNA and/
or protein stability, myc gene amplification, or myc activation
through chromosomal translocation. Because so many cancers
show a direct association with Myc, current research by many
groups is dedicated to elucidating the role(s) these oncoproteins
play in tumor initiation and promotion [3–5] and to exploring
them as potential therapeutic targets [6].
c-Myc is a potent inducer of genomic instability (for reviews,
see Kuttler and Mai [5] and Mai and Mushinski [7]). Recently, it
has become apparent that c-Myc not only acts on the level of
genes [8] and chromatin [9,10] but also actively contributes to
the remodeling of chromosome and telomere positions in inter-
phase nuclei [11] (for reviews, see Mai and Garini [12,13]).
Remodeling of chromosome positions leads to temporary al-
terations in the spatial organization of chromosomes in the
nucleus. As we have shown recently, nuclear reorganization of
telomeres may result in the formation of telomeric aggregates
and may lead to the formation of dicentric chromosomes [11].
In this study, transient c-Myc deregulation mediated the forma-
tion of telomeric aggregates in interphase nuclei. Telomeric
aggregates are clusters of telomeres that cannot be further
resolved at a resolution of 200 nm [14]. As assessed by
metaphase chromosome preparations, such telomeric aggre-
gates represent, in part, telomeric fusions that generate dicen-
tric chromosomes and initiate breakage–bridge–fusion (BBF)
cycles. Louis et al. [11] also demonstrated that chromosomes
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alter their positions when c-Myc is experimentally deregu-
lated. Together, these two events of c-Myc–dependent nu-
clear remodeling profoundly alter the genomic stability of the
cell, directly resulting in BBF cycles and karyotypic abnor-
malities such as terminal deletions and unbalanced translo-
cations. Consequently, more complex chromosomal changes
evolve [11–13].
In this present study, we have investigated whether c-Myc
plays an initiating role in the remodeling of centromeric
positions in interphase nuclei, using mouse cells. The kar-
yotype of standard laboratory mouse strains consists of
40 telocentric chromosomes. However, some wild-type
and laboratory mouse strains contain centromerically fused
chromosomes, also known as Robertsonian (Rb) chromo-
somes [15–18].
The three-dimensional (3D) nuclear organization of
mouse centromeres in primary, immortalized, and tumor cells
has been recently determined using mouse lymphocytes
with telocentric chromosomes [19]. This study showed that
nuclear centromeric positions typical of primary mouse lym-
phocytes are significantly altered in immortalized and malig-
nant mouse lymphocytes. The malignant lymphocytes
examined in this study were mouse plasmacytoma cells
(i.e., cells with c-myc activation through chromosomal trans-
location). In this present study, we therefore focused on the
potential impact of c-Myc on alterations in 3D nuclear distri-
butions of mouse centromeres. We reasoned that nuclear
centromere positions might have been altered due to cellular
transformation and/or nuclear remodeling as a result of c-Myc
oncogene activation. To distinguish between these possibil-
ities, we investigated, using a model of conditional and con-
stitutive c-Myc oncoprotein deregulation, whether c-Myc
deregulation was sufficient to mediate changes in 3D nuclear
centromere positions. Moreover, we determined whether a
potential c-Myc–dependent remodeling of the overall centro-
mere organization permitted the generation of Rb chromo-
somes. To address the specificity of c-Myc–dependent effects
on chromosome organization, we examined D106-Myc, a myc
box II deletion mutant Myc protein [20]. The latter does not
confer tumorigenic potential when overexpressed in mouse
proB lymphocytes (Ba/F3) [21] and is unable to mediate the
formation of telomeric aggregates and dicentric chromosomes
in these cells [22]. The present study shows that c-Myc, in a
myc box II–dependent manner, mediates the formation of Rb
chromosomes during the remodeling of centromere positions
and by telomere–telomere fusions at the telocentric termini of
mouse chromosomes.
Materials and Methods
Cells and Cell Culture Conditions
All cells used are listed in Table 1. Primary splenic lym-
phocytes and primary plasmacytoma cells (PCT1G1) were
directly isolated from mice without any in vitro cultivation from
T38HxBalb/c mice (Central Animal Care protocol no. 02-039/
1/2/3). PreB lymphocytes [11,23] were grown in RPMI 1640
with 10% fetal bovine serum (FBS), 1% L-glutamine, 1%
sodium pyruvate, 1% penicillin–streptomycin, and 0.1% b-
mercaptoethanol (Invitrogen/Gibco, Burlington, ON, Canada)
at 37jC in a humidified atmosphere and 5% CO2. Cells were
maintained at a density of around 105 to 106 cells/ml. The
plasmacytoma cell line MOPC460D (a gift from Dr. J. F.
Mushinski, National Institutes of Health) was grown in RPMI
1640 with 10% FBS, 1% L-glutamine, 1% sodium pyruvate,
1% penicillin–streptomycin (all the above reagents are from
Invitrogen/Gibco), and 100 ml of interleukin-6 hybridoma su-
pernatant per 10-ml plate at 37jC in a humidified atmosphere
and 5% CO2. Ba/F3 cells [20,21] with D106-MycER were
grown in RPMI 1640 (Invitrogen, Burlington ON, Canada),
containing 10% FBS (Gibco, Burlington ON, Canada), 1%
WEHI supernatant (interleukin-3), and 0.021% plasmocin
(Cayla, Toulouse, France). Cells were grown and maintained
at a density of approximately 105 to 106 cells/ml.
Conditional c-Myc Expression
MycER in preB cells and MycER or D106-MycER in Ba/F3
cells were activated by 4-hydroxytamoxifen (4HT; Sigma-
Aldrich, Oakville, ON, Canada) at a final concentration of
100 nM in 105 cells/ml [11]. Cells were split 24 hours prior
to induction.
Induction of c-Myc was confirmed by fluorescence immu-
nohistochemistry, as described previously [24]. A cytospin
was made for each time point and for positive and nega-
tive controls (c-Myc–overexpressing mouse plasmacytoma
cells and non–Myc-activated resting B lymphocytes, re-
spectively). Anti–c-Myc (N262) primary antibody was used
at a dilution of 1:100 (Santa Cruz Biotechnology, Santa
Cruz, CA) and visualized by goat anti-rabbit IgG fluorescein
isothiocyanate (FITC) secondary antibody at a dilution of
Table 1. List of Cells Used in This Study.
Cells Studied Characteristics Karyotype
Primary mouse lymphocytes Diploid 40,XX in all cells
Immortalized preB cells carrying MycER Diploid; nontumorigenic in the absence of MycER activation [11,23] 40,XX in all cells
Plasmacytoma cell line MOPC460D Near-tetraploid; from female BALB/c mouse; tumorigenic [11] 75– 82,XXXX,T(12;15)
Primary plasmacytoma cell line PCT1G1 Near tetraploid; v-abl/myc– induced; tumorigenic (unpublished data) 81,XXXX,T(X;11); TsT(X;11)
Immortalized proB cells (Ba/F3) Near-tetraploid; nontumorigenic; from male BALB/c mouse [20,21] 69– 80,XXYY
Carrying MycER Near-tetraploid; tumorigenic only in the presence of MycER activation
[20,21]
69– 80,XXYY
Carrying myc box II deletion mutant D106-MycER Near-tetraploid; nontumorigenic in the presence or in the absence
of D106-MycER activation [20,21]
69– 80,XXYY
More details on these cells can be found in Materials and Methods and in the accompanying references.
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1:100 (Sigma-Aldrich). Imaging and analysis were performed
as described in Fest et al. [21].
Cell Fixation and Chromosome Preparations
Cells were directly harvested from mice or from cell
culture. They were spun down at 200g for 10 minutes and
resuspended in 5 ml of 0.075 M KCl for 10 minutes at room
temperature for subsequent 3D fixation of nuclei or for
30 minutes at room temperature for chromosome prepara-
tion. For 3D fixation, a hypotonic solution was overlaid with
1 ml of freshly prepared fixative (methanol/acetic acid, 3:1),
inverted carefully for a couple of times, and centrifuged at
200g for 10 minutes at room temperature. Thereafter, pellets
were resuspended with 5 ml of fixative and washed for two
more times as above. This fixation method yielded nuclei
ready for 3D image acquisition, and results were identical to
those with 3.7% formaldehyde fixation, as also stated else-
where [25]. The ellipsoid nature of lymphocytes was con-
firmed by confocal microscopy [22].
For chromosome fixation, the drop fixation method [26]
was used. For all assays involving metaphase chromo-
somes, a minimum of twenty metaphases was scored.
Peptide Nuclei Acid Fluorescence In Situ Hybridization
(PNA-FISH) with Centromeres and Telomeres
PNA-FISH was performed on both 3D interphase and
two-dimensional (2D) metaphase samples derived from the
above cells. A PNA human centromeric probe (Applied
Biosystems, Foster City, CA) was custom-made to the
sequences listed below.
The PNA centromere probe sequences used in this study
are as follows:
Sequence 1: (N-terminus)Flu-OEE-ATTCGTTGGAAAC-
GGGA-EE(C-terminus)
Sequence 2: (N-terminus)Flu-OEE-CACAAAGAAGTTT-
CTGAG-EE(C-terminus)
Sequence 3: (N-terminus)Flu-OEE-CAGACAGAAGCAT-
TCTCA-EE(C-terminus)
Sequence 4: (N-terminus)Flu-OEE-TGCATTCAACTCA-
CAGAG-EE(C-terminus).
This probe cocktail hybridized to all mouse centromeres
(Figure 3).
A PNA telomeric probe was purchased from DAKO
(Glostrup, Denmark). 3D fixed interphase nuclei were fixed
onto slides using 3.7% formaldehyde/phosphate-buffered
saline. The PNA human centromeric probe was denatured
at 80jC for 5 minutes and then added to slides in conjunction
with the PNA telomeric probe. The slides were denatured at
80jC for 3 minutes, subsequently hybridized for 2 hours at
30jC using the Hybrite system (Vysis; Abbott Diagnostics,
Des Plains, IL), and then washed in 70% formamide/2SSC.
DAPI (0.1 mg/ml) was applied, and, finally, one drop of
Vectashield (Vector Laboratories, Burlington, ON, Canada)
was added. All slides were imaged right away to avoid
changes in imaging conditions and were handled as de-
scribed in 3D Image Acquisition section.
3D Image Acquisition
Image acquisition was performed on 30 interphase nuclei
per cell line using an Axioplan 2 microscope (Carl Zeiss,
Inc. Canada) and an AxioCam HR charge-coupled device
(Carl Zeiss, Inc. Canada). A 63/1.4 oil objective lens (Carl
Zeiss, Inc. Canada) was used at acquisition times of 300 milli-
seconds for FITC (centromere), 200 milliseconds for Cy3
(telomere), and 20 to 50 milliseconds for DAPI (nuclei). Eighty
to 90 z-stacks were acquired at a sampling distance of xy:
107 nm and z :200 nm for each slice of the stack. Axiovision
3.1 software (Carl Zeiss, Inc. Canada) and constrained itera-
tive algorithm [27] were used for deconvolution.
Scoring of Centromere–Telomere Signals in 3D Nuclei
Centromere–telomere hybridization signals were scored
as follows: In nuclei with declustered centromeres, telomere
signals that flanked centromeres from one or two sides were
counted as normal. In contrast, when telomere signals were
flanked by centromere signals on two sides, such signals
were scored as aberrant. Telomere–centromere–telomere
(TCT) signals thus represent a normal nuclear organiza-
tion, whereas centromere–telomere–centromere (CTC) sig-
nals represent an aberrant nuclear organization. Nuclear
domains with clustered centromeres were not included in
this analysis. Note that telomeric signals at a distance of
V 200 nm will be detected as one signal [14].
Spectral Karyotyping (SKY) Analysis
SKY was performed using the ASI (Applied Spectral Im-
aging, Vista, CA) kit for mice in accordance with the supplier’s
hybridization protocols. We used the Spectra Cube (ASI) on an
Axioplan 2 microscope (Carl Zeiss, Inc. Canada) with a 63/
1.4 oil objective and the Case Data Manager 4.0 software
(ASI) for PC to perform analyses. A minimum of 20 meta-
phases was examined for preB (induced and noninduced),
MOPC460D, T38HxBalb/c, and D106 (induced and non-
induced). Metaphases were then analyzed for Rb fusions,
and matching control time points were statistically compared
using Fisher’s exact test. P < .05 was considered significant.
Results
Myc and myc Box II–Dependent Nuclear Remodeling
of Centromere Positions
The 3D nuclear distribution frequencies of centromeres
are significantly changed during immortalization and malig-
nant transformation: Centromeres assume higher distribu-
tion frequencies toward central nuclear positions in mouse
tumor cells than in immortalized and normal mouse lympho-
cytes [19]. To determine the consequences of altered cen-
tromeric organization for the structural organization of
chromosomes, we performed a detailed analysis of the nu-
clear organization of centromeres and telomeres in primary,
immortalized, and malignant mouse lymphocytes (Table 1).
These cell lines were chosen to enable the analysis of
centromeric positions and their remodeling within the same
cell lineage, as cell type–specific variations in centromere
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positions do not lend themselves to a direct comparison of
their respective centromeric distribution frequencies.
Figure 1 highlights representative images of primary
mouse lymphocytes, immortalized mouse preB and proB
lymphocytes, and tumor cells (mouse plasmacytoma cells)
in the absence or in the presence of constitutive or conditional
wild-type or myc box II–deletion mutant (D106) Myc expres-
sion (Table 1). After dual-color hybridization with centromeres
(green) and telomeres (red), the nuclei of primary lympho-
cytes and immortalized preB cells show a predominantly
peripheral organization of centromeres; their telomeres are
found throughout nuclear space (Figure 1, A and B). In
contrast to this nuclear organization, the nuclei of MOPC460D
tumor cells with constitutive deregulation of c-Myc protein due
to T(12;15) exhibit a more central nuclear distribution of
centromeres (Figure 1C ). Their telomeres (red) are shorter,
and some are found in close association with centromeres
(Figure 1C, yellow arrows; data not shown).
Each telocentric mouse chromosome is expected to have
four telomeres because there are four chromatid ends (i.e., two
at each end of the long arm and two at the short centromeric
end of a chromosome). Therefore, the expected hybridization
signals of telomeres and centromeres in mouse interphase
nuclei would be found in the following sequence: Telomeres
(red) will be observed both adjacent to a centromere (green)
and distant from a centromere (Figure 1A, cartoon). This
is due to the presence of telomeres at the short and long
ends of mouse chromosomes, respectively. Nuclear telomere
(red)–centromere (green)–telomere (red) (TCT) signals may
also touch each other if a chromosome is bent.
Our data show that primary mouse lymphocytes display
expected TCT signals (Figure 1A). Similarly, immortalized
preB cells exhibit TCTsignals (Figure 1B). However, the nuclei
of MOPC460D plasmacytoma cells display a different orga-
nization; TCT signals are frequently altered into centromere
(green)–telomere (red)–centromere (green) (CTC) signals,
suggesting a centromere–centromere association, with telo-
meric signals bridging the centromeres (Figure 1C, yellow
arrows, cartoon, and enlarged CTC images in e) (P < .0001).
To examine the 3D distribution patterns of centromeres
and telomeres in conditionally Myc-expressing cells, we
studied preB cells stably transfected with MycER [11,23]
(Table 1). These cells allow for the conditional expression of
c-Myc (Figure W1, A and B). Moreover, in the absence of
c-Myc activation, these cells are diploid (Table 1). Figure 1, D
and E, illustrates the data obtained for preB cells in the
absence of MycER activation (D) and in its presence (E ).
The nuclear organization of CTC is apparent only after
MycER activation (Figure 1E, yellow arrow, cartoon, and
zoomed image e) (P = .02), suggesting an Myc-dependent
nuclear remodeling of centromeres. To verify the Myc de-
pendency of this process, a myc box II deletion mutant
D106-MycER was tested under identical conditions (Figure 1,
F and G; Figure W1, C and D). This deletion mutant, when
overexpressed, is unable to initiate in vivo tumorigenesis of
spontaneously immortalized proB lymphocytes (Ba/F3) [21].
D106-MycER did not induce the nuclear remodeling of cen-
tromeres, and no CTC signal was found (Figure 1, F and G,
cartoon). For the cells studied here, we conclude that the
formation of CTC appears to be dependent on the presence of
Myc and on the presence of myc box II.
c-Myc and myc Box II–Dependent Formation
of Rb Chromosomes
The analysis of TCT versus CTC signals in 3D images is
complex, and not all potential CTC signals will be found or
will be correctly assessed due to the clustering of centro-
meres at the nuclear periphery (see also Sarkar et al. [19],
Solovei et al. [28], and Weierich et al. [29]). We therefore
decided to tackle the question of centromere remodeling by
molecular cytogenetics. Using this approach, we investigat-
ed whether the altered nuclear organization of centromeres
impacts on the structural organization of chromosomes, par-
ticularly on the formation of Rb chromosomes. In mouse Rb
chromosomes, telocentric chromosomes become biarmed
due to the fusion of centromeres of the two individual telo-
centric chromosomes.
To address the question of Rb chromosome formation in
our cell models, we performed SKY of primary mouse lym-
phocytes, mouse plasmacytoma cells (MOPC460D), mouse
diploid immortalized preB cells with and without MycER
activation, and near-tetraploid mouse BaF/3 cells (immortal-
ized proB cells) in the presence or in the absence of wild-type
MycER or D106-MycER activation (Table 1 and Figure 2;
Figure W1). Twenty metaphases were examined for each
cell type. In contrast to primary lymphocytes of T38HxBalb/c
mice that did not exhibit Rb chromosomes (Figure 2A),
MOPC460D tumor cells showed a significant number of Rb
chromosomes per metaphase (P < .0001): Fifteen of 20
MOPC460D metaphases showed one or more Rb chromo-
somes; 26 Rb chromosomes were observed in 15 meta-
phases (Figure 2B, white arrows).
It is noteworthy that MOPC460D cells displayed a non-
random involvement of specific chromosomes in the forma-
tion of Rb chromosomes, such as chromosomes 1, 3, 8, 14,
15, 17, and X (Table 2). Out of these, chromosome 15 was
Figure 1. Nuclear centromere and telomere distribution patterns. Representative images of dual-color hybridization of mouse lymphocytes with a centromere probe
(green) and a telomere probe (red) on interphase nuclei (blue). Panel (A–G) Different lymphocyte cell nuclei: Panel (A) primary lymphocyte nucleus of T38HxBalb/c;
Panel (B) nucleus of preB cell; Panel (C) nucleus of MOPC460D; Panel (D) preB cell nucleus without MycER activation 30 hours after mock treatment with etha-
nol; Panel (E) preB cell nucleus 30 hours after MycER activation; Panel (F) Ba/F3 cell nucleus withoutD106-MycER activation 30 hours after mock treatment with ethanol;
Panel (G) Ba/F3 cell nucleus 30 hours after D106-MycER activation. Each panel illustrates a nucleus in 2D Panel (A–G, a) and in 3D Panel (A–G, b–d). Among 3D
panels, (b) represents dual-color hybridization, with centromeres in green and telomeres in red; (c) illustrates centromeric signals only; and (d) shows telomeric
hybridization signals. Panels (C and E, e) Enlarged 3D views of CTC hybridization signals (green–red–green) that are also highlighted by yellow arrows in Panel (C) and
Panel (E), respectively. In addition, telomere–centromere hybridization signals are highlighted in small cartoons on the right side of each panel. Scale bars are given in
3D panels and represent sizes in nanometers.
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most frequent (found 24 times in Rb fusions in the 15 Rb
chromosome–carrying metaphases), followed by chromo-
somes 1 and 14 (found 21 times in 15 Rb chromosome–
carrying metaphases) (Table 2).
To analyze the impact of Myc on the formation of Rb chromo-
somes, we used preB cells and studied them in the absence
and in the presence of MycER activation (Figure 2, Panels C
and D, respectively). Although non–MycER-activated preB
cells did not exhibit Rb chromosomes (Figure 2, Panel C),
MycER-activated preB cells showed Myc-dependent forma-
tion of Rb chromosomes. Thirty-three percent of metaphases
(6/20) showed formation of Rb chromosomes within 30 hours
Figure 2. SKY of metaphases derived from the cells of this study. Representative images from SKY analyses are shown: Panel (A) primary lymphocytes from
T38HxBalb/c mice; Panel (B) MOPC460D; Panels (C and D) preB cells in the absence Panel (C) or in the presence Panel (D) of MycER activation; Panels (E and F)
Ba/F3 D106-MycER without Panel (E) or with Panel (F) D106-MycER activation. White arrows point to Rb fusion chromosomes. The Rb (8;8) in Ba/F3 cells is
constitutional and has been noted previously [21]. Each panel shows a representative image for each cell type; however, layout is the same for all: (a) the raw image of
a metaphase; (b) the classified image of the metaphase; (c) the inverted DAPI-banded image of the metaphase; and (d) the karyotype table of the metaphase.
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(Figure 2, Panel D, arrows; P = .02). During this observation
period, we did not note any specific chromosome combina-
tions that were involved in the formation of Rb chromosomes.
The Myc dependency of this structural chromosomal
change was confirmed with the myc box II deletion mutant
D106. The conditional expression of D106-MycER did not
lead to the formation of Rb chromosomes in Ba/F3 cells
(Figure 2, Panels E and F, respectively), whereas the induc-
tion of wild-type MycER in Ba/F3 cells did. Chromosomes X
and 5 were most frequently involved in the formation of Rb
chromosomes subsequent to wild-type MycER activation of
Ba/F3 cells (P = .0001 and P = .02, respectively, 30 hours
after Myc activation) (data not shown).
The above data suggest that: 1) nuclear centromere
organization impacts on chromosomal order permitting the
formation of Rb chromosomes; and 2) Myc deregulation
leads to the formation of Rb chromosomes in a myc box II–
dependent manner.
Rb Chromosomes Form By Centromere–Telomere–Fusion
in an Myc-Dependent Manner
Using dual-color FISH with centromeres and telomeres
on metaphase chromosomes, we next examined whether
the Rb chromosomes seen displayed centromere–telomere
fusions. Using the cell lines listed in Table 1, we analyzed
20 metaphases per cell type and determined the presence
of telomeric signals at the fusion points of centromeres in Rb
fusion chromosomes (Figure 3). We noted the presence of
telomeric hybridization signals on Rb chromosomes formed
after MycER activation in preB cells (Figure 3, Panel E,
arrows and zoomed images), MOPC460D cells (Figure 3,
Panel B, arrows and zoomed images), and PCT1G1 cells
(a primary mouse plasmacytoma cell line; Figure 3, Panel C,
(arrows and zoomed images)). In contrast, no Rb chromo-
somes were seen in primary lymphocytes (Figure 3, PanelA),
non–MycER-activated preB cells (Figure 3, Panel D), or
D106-MycER–activated and control Ba/F3 cells (Figure 3,
Panels G and F, respectively). We conclude that constitutive
or conditional wild-type Myc deregulation, but not deregu-
lated D106-Myc protein expression, led to the formation
Table 2. Summary of Chromosomes Participating in the Formation
of Rb Chromosomes in MOPC460D Cells in a Nonrandom Manner.
Chromosome Number Times Involved in Rb Fusions P
1 21 < .0001
3 11 .001
8 18 < .0001
14 21 < .0001
15 24 < .0001
17 14 .0001
X 11 .001
The numbers given are derived from the analysis of 20 metaphases. Fifteen
of these 20 metaphases carried one or more Rb chromosomes. The
involvement of each chromosome in the formation of Rb chromosomes is
given, and the respective significance is indicated. For further details, see text
and Materials and Methods section.
Figure 3. Centromere– telomere FISH performed on metaphases of mouse lymphocytes. Representative images are shown: Panel (A) primary lymphocyte meta-
phase from a T38HxBalb/c mouse; Panel (B) metaphase of MOPC460D; Panel (C) partial metaphase of the primary mouse plasmacytoma PCT1G1; Panel (D)
preB cell metaphase without MycER activation; Panel (E) preB metaphase 30 hours after MycER activation; Panel (F) Ba/F3 cells without D106-MycER activa-
tion; Panel (G) Ba/F3 cells 30 hours after D106-MycER activation. In each panel, (a) represents dual-color FISH hybridization signals of telomeres (red) and
centromeres (green); (b) shows only centromeric signals; and (c) shows only telomeric signals. Rb chromosomes shown in Panel (B), Panel (C), and Panel (E) are
highlighted with white boxes and arrows, and then enlarged (d) to observe CTC signals. Note small telomeric signals at Rb fusion in Panel (B, d). The overall
telomeric length in MOPC460D is reduced in comparison to the telomeric length of primary B cells and preB cells (data not shown; Figure 1, Panel C).
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of Rb chromosomes that carry telomeric signals at their
fusion points.
The above data further suggest that critically shortened
telomeres are unlikely to cause the formation of Rb translo-
cation chromosomes in this experimental setting. Instead, it
is likely that c-Myc–dependent uncapping of telomeric se-
quences plays an initiating role in this event. This conclusion
is very likely due to the short time period required to permit
such fusions: 30 hours after a single c-Myc deregulation were
sufficient to allow for the formation of Rb translocation chro-
mosomes that carry telomeric signals in fused centromeres.
The latter was observed for both preB and Ba/F3 cells.
Discussion
Rb Chromosomes in Different Species and in Cancer
Rb chromosomes represent structural genetic changes
that occur in many species, including plants [30], cattle [31],
some strains of mice [16,32], fish [33], and humans [34].
In humans, such Rb chromosomes are among the most
common structural aberrations in aborted fetuses and new-
borns [35–37]. Moreover, Rb chromosomes in humans have
been found as acquired or constitutional genetic lesions in
hematologic cancers [34,38] and in solid tumors [39,40].
In addition, they have been reported at the onset of acute
myelogenous leukemia [41].
Does It Matter to Have De Novo Rb Chromosomes
in a Cell?
One could assume that Rb chromosomes merely remodel
nuclear organization, thereby placing two chromosomes into
a ‘‘forced’’ unit and into a new nuclear position or environ-
ment, without any further impact on the cell. Several lines of
evidence suggest, however, that this new fused entity can be
different and that the remodeling of two chromosomes into
one Rb chromosome may possibly have wide-ranging
effects. For example, it has been described that the forma-
tion of an Rb chromosome suppresses somatic recombina-
tion [42]. Another study linked Rb chromosomes to altered
nuclear architecture and subfertility in mice [43]. In tumor
induction studies with Rb-carrying or non–Rb-carrying
BALB/c mice and congenics, it has been shown that the
type of c-myc–activating chromosomal translocations in
mouse plasmacytoma cells is altered in Rb6.15–carrying
mice compared to BALB/c mice with telocentric chromo-
somes [44]. In humans, Rb translocations occur between
acrocentric chromosomes of the D and G groups 13–15 and
21–22. These Rb translocations most frequently involve
chromosomes 13 and 14. Carriers of such chromosomes
are at risk for chromosomal nondisjunction leading to off-
spring with trisomy or uniparental disomy (UPD) following
pregnancy rescue. Although UPD for chromosomes 13, 21,
and 22 does not show apparent phenotypes, UPD for
chromosomes 14 and 15 results in abnormal phenotypes
[37]. Altogether, the above data suggest that a nuclear
reorganization of two single chromosomes into one Rb
chromosome may have a broad impact on the overall
physiological state of Rb-carrying cells, on the function of
the organism, and on oncogenesis.
Randomness and Nonrandomness of
Rb Chromosomes Formed
Our present data show that mouse plasmacytoma cells
(MOPC460D) with constitutive c-Myc deregulation and in
long-term culture develop significant numbers of Rb chro-
mosomes. Specific Rb chromosomes are found more fre-
quently than others. For example, chromosomes 1, 3, 8, 14,
15, 17, and X are involved in Rb translocations almost all the
time, although with different individual frequencies (Table 2).
It is possible that the nonrandom composition of Rb fusions
was selected during long-term culture, in combination with
constitutively elevated levels of c-Myc protein. However, the
above data also support current concepts suggesting that
chromosomal proximity in interphase nuclei is required for
intrachromosomal rearrangements (for review, see Meaburn
et al. [45]). One could therefore assume that those chromo-
somes that were involved in Rb fusions more often than
others resided in centromere clusters or in close nuclear
proximity to each other in interphase nuclei. In fact, a
previous study undertaken by our group suggested that
specific chromosomes involved in unbalanced translocations
were found in close nuclear proximity, showing considerable
overlap as a result of c-Myc deregulation [11]. Moreover,
studies into the 3D organization of centromeres suggest
that their distribution is altered in tumor cells such as
MOPC460D, where centromeres are no longer found with
high frequency toward the nuclear periphery (as is commonly
observed for primary lymphocytes) but are instead located in
a more central nuclear space [19]. If we also consider that
mouse chromosomes have a > 99% sequence homology in
their telocentric regions [46], fusion events become very
possible. They have indeed been reported in detail for Mus
musculus speciation [15–18]. Thus, we propose that chro-
mosomal positions and telocentric sequences contribute to
both the specificity and the randomness of Rb chromosome
formation in mouse cells. In accordance with this notion, we
have observed that a single MycER activation in preB cells
led to the formation of Rb chromosomes but did not result in
the generation of nonrandom combinations of Rb chromo-
somes. Of note, PCT1G1, a primary plasmacytoma cell line
that displayed Rb chromosomes (Table 1 and Figure 3), also
did not show nonrandom constitution of Rb chromosomes,
whereas a single wild-type MycER activation in Ba/F3 cells
led to preferential formation of certain Rb chromosome combi-
nations. From these findings, we conclude that c-Myc dereg-
ulation permits the formation of random and nonrandom Rb
chromosomes within the given context of nuclear chromosomal
and centromeric positions and of telocentric sequences.
Mechanisms of Rb Chromosome Formation in the Context
of c-Myc–Dependent Oncogenic Nuclear Remodeling
Previous studies have suggested that Rb chromosomes
form after recombination [46,47], centric misdivision and
rejoining [30], or fusion [48]. Our data support the concept of
fusion but add a new dimension: Rb fusions are initiated by
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c-Myc oncogene deregulation and depend onmyc box II. After
c-Myc deregulation, Rb chromosomes are generated when
centromeric telomeres of mouse telocentric chromosomes
fuse. This telomeric fusion is a direct consequence of the
recently described Myc-dependent formation of telomeric
aggregates [11] and of the nuclear remodeling of centromeres
(this study and Sarkar et al. [19]). In this context, c-Myc–
induced telomeric aggregates will lead to end-to-end fusions
of telomeres on both ends of the chromosomes. Telocentric
telomere fusions will generate Rb chromosomes, whereas
telomeric fusions of the long arms of two chromosomes will
create dicentric chromosomes. The latter usually initiates BBF
cycles, which we have described recently [11].
The novel finding of this study, thus, is a direct link
between Rb chromosome formation and c-Myc deregulation
that occurs in a myc box II–dependent manner and through
telomeric fusions at telocentric ends of mouse chromo-
somes. Whether previously observed mouse and rat Rb
fusions involve myc box II and telomeric fusions is currently
unknown. For example, Rb chromosomes were observed in
Rat1A fibroblasts [49,50] and in transgenic MMTV-myc/p53
mice [51]. One of the primary tumors that formed in these
mice, 67a5, contained RbX.15 and Rb11.15 [51]. Further-
more, Rb chromosomes were common in a model of mouse
skin tumorigenesis (unpublished data).
Theoretically, the c-Myc–dependent telomere-mediated
centromeric fusion process that creates mouse Rb chromo-
somes does not require additional mechanisms. However, it
is likely that c-Myc’s ability to induce DNA breaks [52–54]
may contribute to a second molecular pathway of Rb chro-
mosome formation. Whether the latter mechanism would act
alone or in concert with the former is currently unknown.
The requirement of myc box II for mouse Rb chromosome
formation confirms that the process of Rb chromosome
formation is Myc-dependent and involves telomeric fusions
[22]. The present study opens new avenues into investiga-
tions about myc box II–related Myc-cooperating proteins
that may play a role in this Myc-induced nuclear remodeling
of centromeres.
Finally, this study highlights the fact that c-Myc–depen-
dent telomeric fusions at telocentric mouse chromosomes do
not require critically short telomeres. This conclusion is
based on the following: 1) compared to human telomeres,
mouse telomeres are long (in the range of 20–60 kb,
depending on the mouse strain) [55]; and 2) telomeric
fusions at telocentric chromosomes occurred within 30 hours
of experimentally induced c-Myc deregulation. This fact
precludes the idea that, in this experimental context, after
multiple divisions and/or mouse generations, telomeres
reached a critically short state that predisposed them to
fusions. Instead, these findings suggest a direct impact of
c-Myc on the capping of telomeres. Future studies will
address these potential interactions.
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Figure W1. MycER activation in preB and D106-carrying Ba/F3 cells. preB cells are shown without (A) and after (B) 4HT activation of MycER (see also Materials
and Methods section). Representative images illustrate D106-MycER activation for D106-carrying Ba/F3 cells without (C) and with (D) D106-MycER activation.
White arrows (A and C) point to nonactivated cells containing D106-MycER in the cytoplasm of the cell, and yellow arrows (B and D) demonstrate that D106-MycER
is translocated to the nucleus on D106-MycER activation.
